News

PHEXCOM

Solution BY Communication

Call：+86 021-55807300

Position：Home > News >

Biogen conference likely linked to 'tens of thousands' of COVID-19 cases, researchers say

It’s been some months since Biogen’s Februarymanagementconference has been in the news,but as the pandemic drags on, researchersare now linking the early “superspreadingevent” withtens of thousands o
2020/8/25
FDA chief Hahn walks back plasma claims, but his correction still missed the mark, experts say

With the emergency use authorization (EUA) for convalescent plasma to treat COVID-19, the FDA and Commissioner Stephen Hahn, M.D., touched off a controversy—particularly about his presentation of the
2020/8/25
AbbVie's Skyrizi stands to gain as docs move away from older psoriasis meds—Amgen's Otezla included

In an increasingly crowded psoriasis market, a raft of next-gen biologics is looking to topple an older suite of drugs for sales supremacy. Dermatologists seem to be on board with that shift, a good
2020/8/24
Takeda to offload Japan consumer health unit to Blackstone for $2.3B

After months of rumors, Takeda has finally unveiled a deal to sell its Japanese consumer health business to Blackstone Group. The U.S. private investment shop couldpayJPY242 billion ($2.3 billion) fo
2020/8/24
Roche's Polivy gets thumbs-up from England's cost watchdog after earlier rejection

With its three blockbuster oncology meds under assault from biosimilar rivals, Swiss drugmaker Roche is looking to its next-gen therapies for a boost. New lymphoma launch Polivy faced a setback earli
2020/8/21
Compounder SCA Pharma recalls heparin products over potentially lethal preservative mix-up

SCA Pharma set out to expand capacity for key drugs earlier this summer. Now, thecompounding pharmacy ispullingone of itscritical meds—common blood thinner heparin—from hospitals nationwideover inacc
2020/8/21
CureVac in 'advanced' talks with EU to supply 225M coronavirus vaccine doses

Officials in Europe have engaged some of the world's largest biopharma companies in COVID-19 vaccine supply talks, but now Germany’s CureVac is moving into advanced supply negotiations with the union
2020/8/20
With Gilead's JAK inhibitor on the shelf, AbbVie's Rinvoq stands to gain big in rheumatoid arthritis: analysts

With its megamerger with Allergan in the books, AbbVie is focusing its growth on a stable of homegrown meds, including recent rheumatoid arthritis launch Rinvoq. Signs were looking good already—and a
2020/8/20
Merck's Keytruda sets up Opdivo showdown with esophageal cancer victory

After archrival Opdivo from Bristol Myers Squibb posted a pair of esophageal cancer wins last week, Merck & Co.’s Keytruda is determined not to be left behind. The New Jersey drugmaker Wednesday
2020/8/19
Roche, Regeneron join forces to more than triple manufacturing of COVID-19 antibody cocktail

Despite hundreds of potential therapies for COVID-19 looking to make their case, very few have crossed the finish line. One promising candidate, Regeneron's two-antibody cocktail, has earned early pl
2020/8/19

Excipients